Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 04, 2015 9:20 PM ET

Pharmaceuticals

Company Overview of Endo International plc

Executive Profile

Donald W. DeGolyer

Special Advisor to the Chief Executive Officer, Endo International plc
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 8 different industries.

See Board Relationships
52$7,155,060
As of Fiscal Year 2014

Background

Mr. Donald W. DeGolyer, also known as Don, has been a Special Advisor to the Chief Executive Officer at Endo International plc (formerly, Endo Health Solutions Inc) since March 2015. Mr. DeGolyer served as the Chief Operating Officer, Pharmaceuticals at Endo Pharmaceuticals Inc. until March Mr. DeGolyer served as the Chief Operating Officer of Pharmaceuticals at Endo International plc (formerly Endo Health Solutions Inc) from August 1, 2013 to March 1, 2015. Mr. DeGolyer ...

Corporate Headquarters

Minerva House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 268 2000
Fax: --

Board Members Memberships

2012-Present
Vice Chairman

Education

BA
University of Rochester
MBA
Fairleigh Dickinson University

Other Affiliations

Annual Compensation

Salary$660,292
Total Annual Compensation$660,292

Stocks Options

Restricted Stock Awards$1,379,034
All Other Compensation$4,142,236
Unexercisable Options$19,081
Total Number of Options$19,081

Total Compensation

Total Annual Cash Compensation$5,369,791
Total Short Term Compensation$660,292
Other Long Term Compensation$5,521,270
Total Calculated Compensation$7,155,060
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
$2.7M
Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
$1.1M
Michael A. Mussallem Chairman and Chief Executive Officer
Edwards Lifesciences Corp.
$900.0K
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
Mark Christopher Trudeau Chief Executive Officer, President, Director and Member of Portfolio Committee
Mallinckrodt public limited company
$905.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Endo International plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.